NAV
₹125.5900
as of 17 Jun 2026
Expense Ratio
—
see scheme documents
Lumpsum returns (CAGR)
- 1Y
- +8.41%
- 3Y
- +24.06%
- 5Y
- +19.04%
- Since Inception
- +17.82%
SIP returns (XIRR)
- 1Y
- +13.28%
- 3Y
- +17.66%
- 5Y
- +19.81%
- Since Inception
- +18.00%
Performance Comparison
Thinking about Invesco India Large and Mid Cap Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Invesco India Large & Mid Cap Fund - Regular Plan - Growth
- 1Max Healthcare Institute Limited7.07%
- 2Eternal Limited6.26%
- 3Interglobe Aviation Limited6.12%
- 4Icici Bank Limited5.99%
- 5Sai Life Sciences Limited4.69%
- 6Trent Limited4.62%
- 7Prestige Estates Projects Limited4.54%
- 8Bse Limited4.12%
- 9Abb India Limited3.44%
- 10Glenmark Pharmaceuticals Limited3.31%
Investment Objective
Invesco India Large and Mid Cap Fund · Direct · Growth seeks to generate long-term capital appreciation by investing in mid-cap companies — ranked 101st to 250th by market capitalisation. These companies offer a balance of growth potential and relative stability, making them suitable for investors with moderate to high risk appetite.
About This Fund
Invesco India Large and Mid Cap Fund · Direct · Growth is a Large & Mid Cap mutual fund offered by Invesco Mutual Fund. The fund has been operational for over 13 years.
Who Should Invest?
- •Investors with a high risk appetite seeking long-term wealth creation
- •Investors with an investment horizon of 5 years or more
- •SIP investors who can benefit from rupee cost averaging during market fluctuations